Furthermore, the minor allele (326Tyr) in COL4A3 is found to be protective against several definitions of DN, including albuminuria and ESRD, while the strongest protective effect was observed in patients with glycemia (Salem et al., 2019). Here, COL4A3 is linked to liver dysplastic nodule.